Royal Bank of Canada Issues Positive Forecast for Chemed (NYSE:CHE) Stock Price
Chemed (NYSE:CHE – Get Free Report) had its price objective hoisted by Royal Bank of Canada from $667.00 to $674.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target points to a potential upside of 17.10% from the stock’s current […]
